AAVXF
Price
$88.90
Change
+$11.90 (+15.45%)
Updated
Sep 5 closing price
Capitalization
6.41B
IMNN
Price
$5.75
Change
+$0.04 (+0.70%)
Updated
Sep 5 closing price
Capitalization
14.51M
72 days until earnings call
Interact to see
Advertisement

AAVXF vs IMNN

Header iconAAVXF vs IMNN Comparison
Open Charts AAVXF vs IMNNBanner chart's image
Abivax SA
Price$88.90
Change+$11.90 (+15.45%)
Volume$100
Capitalization6.41B
Imunon
Price$5.75
Change+$0.04 (+0.70%)
Volume$34.99K
Capitalization14.51M
AAVXF vs IMNN Comparison Chart in %
Loading...
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AAVXF vs. IMNN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAVXF is a Buy and IMNN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AAVXF: $88.90 vs. IMNN: $5.76)
Brand notoriety: AAVXF and IMNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AAVXF: 4% vs. IMNN: 14%
Market capitalization -- AAVXF: $6.41B vs. IMNN: $14.51M
AAVXF [@Biotechnology] is valued at $6.41B. IMNN’s [@Biotechnology] market capitalization is $14.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AAVXF’s FA Score shows that 1 FA rating(s) are green whileIMNN’s FA Score has 0 green FA rating(s).

  • AAVXF’s FA Score: 1 green, 4 red.
  • IMNN’s FA Score: 0 green, 5 red.
According to our system of comparison, AAVXF is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AAVXF’s TA Score shows that 3 TA indicator(s) are bullish while IMNN’s TA Score has 3 bullish TA indicator(s).

  • AAVXF’s TA Score: 3 bullish, 3 bearish.
  • IMNN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AAVXF is a better buy in the short-term than IMNN.

Price Growth

AAVXF (@Biotechnology) experienced а +15.45% price change this week, while IMNN (@Biotechnology) price change was -2.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

IMNN is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AAVXF($6.42B) has a higher market cap than IMNN($14.5M). AAVXF YTD gains are higher at: 704.525 vs. IMNN (-53.556). IMNN has higher annual earnings (EBITDA): -14.79M vs. AAVXF (-170.04M). AAVXF has more cash in the bank: 104M vs. IMNN (4.73M). IMNN has less debt than AAVXF: IMNN (1.19M) vs AAVXF (92.6M). AAVXF (0) and IMNN (0) have equivalent revenues.
AAVXFIMNNAAVXF / IMNN
Capitalization6.42B14.5M44,241%
EBITDA-170.04M-14.79M1,150%
Gain YTD704.525-53.556-1,315%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M4.73M2,199%
Total Debt92.6M1.19M7,762%
FUNDAMENTALS RATINGS
AAVXF vs IMNN: Fundamental Ratings
AAVXF
IMNN
OUTLOOK RATING
1..100
3051
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
26100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3496
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMNN's Valuation (57) in the Medical Specialties industry is in the same range as AAVXF (63) in the null industry. This means that IMNN’s stock grew similarly to AAVXF’s over the last 12 months.

AAVXF's Profit vs Risk Rating (26) in the null industry is significantly better than the same rating for IMNN (100) in the Medical Specialties industry. This means that AAVXF’s stock grew significantly faster than IMNN’s over the last 12 months.

AAVXF's SMR Rating (99) in the null industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that AAVXF’s stock grew similarly to IMNN’s over the last 12 months.

AAVXF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for IMNN (96) in the Medical Specialties industry. This means that AAVXF’s stock grew somewhat faster than IMNN’s over the last 12 months.

AAVXF's P/E Growth Rating (100) in the null industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that AAVXF’s stock grew similarly to IMNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAVXFIMNN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
37%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
32%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
27%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 17 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
31%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
35%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AAVXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDHY49.270.10
+0.20%
Fidelity Enhanced High Yield ETF
IBDQ25.120.02
+0.08%
iShares iBonds Dec 2025 Term Corp ETF
PEVC27.39N/A
N/A
Pacer PE/VC ETF
AAPX25.12-0.03
-0.14%
T-Rex 2X Long Apple Daily Target ETF
IEZ18.98-0.20
-1.04%
iShares US Oil Equipment & Services ETF

AAVXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, AAVXF has been loosely correlated with BPMUF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AAVXF jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AAVXF
1D Price
Change %
AAVXF100%
+15.45%
BPMUF - AAVXF
47%
Loosely correlated
N/A
CSCI - AAVXF
46%
Loosely correlated
N/A
SRPT - AAVXF
45%
Loosely correlated
+1.35%
ABCZF - AAVXF
31%
Poorly correlated
N/A
IMNN - AAVXF
28%
Poorly correlated
+0.61%
More

IMNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNN has been loosely correlated with REPL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNN jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+0.61%
REPL - IMNN
61%
Loosely correlated
+8.95%
ABVX - IMNN
57%
Loosely correlated
+2.90%
SPRO - IMNN
41%
Loosely correlated
+0.47%
MRUS - IMNN
36%
Loosely correlated
+1.87%
CLSD - IMNN
30%
Poorly correlated
-1.23%
More